Protein vital for breast cancer metastasis discovered
A research team have identified a protein that binds breast cancer cells together, allowing them to metastasise, which could be significant in the development of cancer therapies.
List view / Grid view
Oncology is a branch of medicine that deals with the prevention, diagnosis and treatment of cancer.
A research team have identified a protein that binds breast cancer cells together, allowing them to metastasise, which could be significant in the development of cancer therapies.
A study has used a proteomic method to uncover why some melanoma tumours do not respond to immunotherapy, which could improve treatments.
A protein that causes pancreatic ductal adenocarcinoma has been identified as a therapeutic target by researchers.
Researchers have found that inhibiting a kinase in mice leads to the death of prostate cancer cells, providing a potential therapeutic target.
Researchers have found a molecule, which when deleted, increases leukaemia sensitivity to natural killer cells and is a drug target.
A study has found that removing a particular kind of macrophage enables the immune system to attack tumours, providing a potential drug target.
Researchers have discovered the roles that immune cells play in tumour growth and breast cancer immunotherapy which could aid in drug development.
Researchers have discovered that MYC cancers use the cell’s machinery to make lipids and identified a lipid signature, which could be exploited in the development of new therapies.
The structure of a key receptor involved in tumour metastasis has been imaged in a study, providing opportunities to develop cancer treatments.
A study has revealed a drug target for skin cancers which regulates the differentiation of cells and the roles they conduct in the body.
Researchers have revealed a key inflammation mechanism that contributes to melanoma brain metastasis and could be a therapeutic target.
New findings show that the environment for pancreatic cancers plays a role in its metastasis, revealing a new potential drug target.
A new study has revealed that glioblastomas contain four different types of cell which the researchers say should be treated separately.
Using a compound called PTC596 in combination with other drugs, researchers effectively treated pancreatic cancer in mice.
A study has found that signals from interferons can be blocked, allowing the immune system to attack tumours which provides a potential target.